Welcome to the Entegris second quarter 2023 earnings conference call. At this time, all participants have been placed on a listen-only mode. The floor will be open for questions following the presentation. If you would like to ask a question at that time, please press star one on your telephone keypad. If at any point your question has been answered, you may remove yourself from the queue by pressing star two. Others can hear your questions clearly, we ask that you pick up your handset for best sound quality. Lastly, if you should require operator assistance during today's call, please press star zero. I would now like to turn the call over to Bill Seymour, Vice President of Investor Relations. Good morning, everyone. Earlier today, we announced the financial results for our second quarter of 2023. Before we begin, I would like to remind listeners that our comments today will include some forward-looking statements. These statements involve a number of risks and uncertainties, and actual results could differ materially from those projected in the forward-looking statements. Additional information regarding these risks and uncertainties is contained in our most recent annual report and subsequent quarterly reports that we have filed with the SEC. Please refer to the information on the disclaimer slide in the presentation. On this call, we will also refer to non-GAAP financial measures as defined by the SEC and Regulation G. You can find a reconciliation table in today's news release, as well as on our IR page of our website at entegris.com. On the call today are Bertrand Loy, our CEO, and Linda LaGorga, our CFO. With that, I'll hand the call over to Bertrand. Thank you, Bill. Good morning to all, and welcome again, Linda, to the Entegris team. I would start by saying that I am pleased with our solid execution in the second quarter, especially in light of the dynamic industry environment. During the quarter, we delivered strong results within or above our guidance. Sales were $901 million, EBITDA margins were over 27%, and non-GAAP EPS were $0.66. Let me make a few additional comments on our financial performance. Sales were down sequentially, as expected, but we did see growth in product lines that are of increasing importance to our customers' technology roadmaps. These include liquid filtration and etching chemistries, which also explain the relative strength in our MC and SCEM divisions in the second quarter. Meanwhile, performance was mixed, but in line with our expectations in our CapEx-driven solutions. While we saw a contraction in sales of FOUPs and gas filters, consistent with the decline in WFE, we did see steady demand for our fluid handling and gas purification solutions in line with the level of new fab construction activity, which so far this year remains resilient. In terms of profitability, we continued to execute well and performed in line with our expectations. Next, I would like to highlight a few important items that the team is focused on. First, on the CMC integration. One of the guiding principles of the integration is the fast and effective migration to a common ERP system. To that end, we have already completed three major ERP transitions in the past 12 months, and I don't want to jinx it, but we expect to complete the final go-live migration in just a few days. A major accomplishment for the team, certainly an accomplishment that puts us on track to achieve our $75 million of run rate cost synergy target by the fourth quarter. As you know, debt paydown is a high priority for us, and divestitures of non-core assets are a significant lever we are using to reduce our debt. Far this year, we have entered into definitive agreements for the sale of three businesses, totaling more than $1 billion in proceeds. Two of these businesses were part of CMC Materials. The first of those was QED, which closed in March with $135 million in proceeds. The second was the sale of Electronic Chemicals, which we announced on May 10th for $700 million in proceeds. We have already received regulatory approval for the EC transaction in several jurisdictions, including the U.S. Just as a reminder, we do not need the regulatory approval in China for this transaction. We are currently waiting for a few final regulatory approvals and continue to expect the EC transaction will close by the end of this year. On June 5th, we announced the termination of our distribution agreement for copper plating chemistries with Element Solutions in exchange for $200 million. We received $170 million at the time of announcement and expect to receive the balance no later than this, once customer transitions are completed. We have used all of the proceeds received from the QED and Element transactions for debt paydown, and the $700 million of proceeds from the EC sale, when realized, are also expected to be used to pay down debt. That brings us to one more potential divestiture, PIM, which sells drag reducing agents for the oil and gas industry and which also was a part of CMC Materials. The PIM business has performed very well so far this year. We do intend to sell this business. We will provide an update on this when we have more to communicate. Another important update I would like to share is that we will be combining the SCEM and APS divisions starting next month. The SCEM and APS businesses are highly complementary. They are both unit-driven, and the majority of what they sell are specialty materials that are consumed in the manufacturing of semiconductors. Our customers will benefit from a more robust end-to-end solution set, critical to their roadmaps, a solution set that reduces their time to yield and provides superior cost of ownership. Frankly, we considered doing this immediately at the close of the CMC transaction, we did not have a definitive line of sight to the divestitures we were contemplating. Now that those divestitures are done or solidly in the works, combining the two divisions into one will enhance its size, scale, and focus. As we always do, we continue to look at our cost structure and align it with the current industry environment. To that end, we would expect our total headcount to be down approximately 5% this year, even net of new hires in our new facility in Taiwan. While it is critical we get our cost structure where it needs to be in the short term, it is equally critical we get ready when the industry ultimately returns to growth. To that end, the capacity expansions in Taiwan and Colorado Springs are vital for us to fully realize our long-term growth potential. Our facility in Taiwan is expected to begin initial shipments later this year, and Colorado Springs will begin shipments in early 2025. In addition, we are also using this downturn to our advantage, spending valuable time collaborating with our customers while making elevated levels of R&D spending to support our promising R&D pipeline. Looking at the rest of 2023, for the full year, we continue to expect the market will be down in the mid-teens and given our strong position in the new technology nodes, we also continue to expect to outperform the market by at least 6 points. Putting it all together, we continue to expect our pro forma sales in 2023 to be down approximately 8%. We also continue to expect EBITDA will be approximately 27%-28% of revenue for the year. We are increasing our full year 2023 non-GAAP EPS expectation to greater than $2.50 per share. While our expectations for industry recovery in the second half of this year are modest, we are extremely optimistic about the long-term secular growth of the semiconductor industry on the way to $1 trillion by 2030. The growth is being driven by overall demand for both logic and memory chips and the many end markets that will drive that growth, including the much-discussed emergence of AI and, of course, power electronics and high-performance computing, to name just a few. In addition to that, device architectures like gate-all-around and higher layer count structures are becoming much more complex, trends which ultimately play to our strength. These trends and Entegris' breadth of capabilities in material science and materials purity are expected to translate into rapidly expanding content per wafer and market share growth for Entegris. I want to take a moment to thank our customers for the trust and confidence they place in Entegris, and I would like to thank the Entegris team for their dedication and strong execution as we navigate this dynamic industry environment. Let me turn the call to Linda. Linda? Good morning, everyone, and thank you, Bertrand. I've had a terrific first three months at Entegris, traveling to our U.S. sites and getting to know the team. I am delighted to be on a team that is eager to win, and I'm proud to review solid results on this first call as the new CFO of Entegris. Our sales in the second quarter were $901 million, down 11% year-over-year on a pro forma basis and down 2% sequentially. Sales were up 30% year-over-year on a reported basis. As a reminder, the CMC transaction closed in July 2022. FX negatively impacted revenue by approximately $9 million year-over-year on a pro forma basis and negatively impacted revenue by $5 million sequentially in Q2. FX headwinds were primarily driven by the Japanese yen. Gross margin on a GAAP and non-GAAP basis was 42.6% in the second quarter, within our guidance range. The sequential decline in the non-GAAP gross margin was driven by lower volumes and the Taiwan facility ramp-up costs. In addition, we had an FX benefit in Q1 that did not repeat in Q2 as expected. Operating expenses on a GAAP basis were $117 million in Q2. Non-GAAP items totaled $67 million and included a $155 million gain on the termination of our distribution agreement with Element. Operating expenses on a non-GAAP basis in Q2 were $183 million, slightly below our guidance. As you would expect, we continue to manage our cost structure in this dynamic environment. Operating income on a GAAP basis in Q2 was $268 million, and non-GAAP operating income was $201 million. Adjusted EBITDA in Q2 was $245 million, or just over 27% of revenue within our guidance range. The GAAP tax benefit in the quarter was driven by the EC asset held for sale treatment. The non-GAAP tax rate was approximately 16%. GAAP diluted EPS was $1.31 per share in the second quarter, which includes a gain on the termination of our distribution agreement with Element. Non-GAAP EPS was $0.66 per share above our guidance. Looking at our performance by division. The year-over-year sales comparisons I am referencing are on a pro forma basis for the SCEM and APS divisions. MC sales in the quarter of $284 million were up 3% from last year and up 5% sequentially. The sequential sales growth was driven by liquid filtration and gas purification solutions. Adjusted operating margin for MC was 35.5% for the quarter. The sequential margin decline was driven primarily by costs associated with the ramp of our new facility in Taiwan and the impact of lower plant production due to the inventory reductions. AMH sales in Q2 of $190 million were down 15% versus last year and down 13% sequentially. As Bertrand indicated, the sequential sales decline in AMH was driven by products more tied to WFE, like FOUPs, and was partially upset by growth in fluid handling products, which are more tied to fab construction, which again has been more resilient. Adjusted operating margin for AMH was approximately 19%, down sequentially, primarily driven by lower volumes and the ramp of our new facility in Taiwan. SCEM sales in Q2 of $200 million were down 11% year-over-year and up 1% sequentially. The modest sequential sales increase was driven by growth in etching chemistries. Adjusted operating margin for SCEM was approximately 10% for the quarter, in line with our expectations. The modest sequential margin decline was primarily driven by unfavorable mix. APS sales in Q2 of $241 million were down 21% year-over-year and down 4% sequentially. The year-over-year sales decline was primarily driven by the overall decline in the memory market and the impact of the sales restrictions in China. The sales decline sequentially was driven primarily by lower volumes across most product lines, particularly in memory, memory applications. We did continue to see strong growth in SiC slurries in the quarter. Adjusted operating margins for APS of approximately 23% were up modestly sequentially. Moving on to cash flow in the balance sheet. Second quarter cash flow from operations was $127 million. Free cash flow was $11 million. We continue to be committed to improving free cash flow. Excluding Electronic Chemicals inventory balances, which were moved to asset held-for-sale, our inventory was down 5% in the second quarter. That is progress, but more work needs to be done, and this will remain a major area of focus for the team in the second half of the year. CapEx for the quarter was $116 million. We have moderated our CapEx investments in response to market conditions and now expect to spend approximately $450 million in total CapEx in 2023, lower than our previous expectation of $500 million. Next, let's discuss our capital structure. We remain committed to lowering our leverage toward our target of 3.5x gross leverage by the end of 2024. As Bertrand mentioned, a key component of our debt paydown includes divestitures. At the end of Q2, our gross debt was $5.6 billion, and our net debt was $5 billion. This equates to a gross leverage ratio of 5.2x and a net leverage ratio of 4.7x pro forma for the announced cost synergies. Our variable rate debt is expected to be a bit more than 10% of the total outstanding debt. The blended interest rate on our debt portfolio is approximately 5.5%. Overall, a very solid rate considering the interest rate environment we've experienced since we announced the CMC deal. Moving on to our Q3 outlook. We expect sales to range from $875 million-$900 million. We expect the EBITDA margin to be approximately 26%-27%. We expect GAAP EPS to be $0.23-$0.28 per share, and non-GAAP EPS to be $0.57-$0.62 per share. Let me provide some additional modeling items. We expect gross margin to be 41%-42% in the third quarter, both on a GAAP and non-GAAP basis. The modestly lower margin compared to Q2 reflects the temporary impact of the termination of our distribution agreement with Element, higher costs associated with the ramp of our new facility in Taiwan, and lower plant volumes driven by our continued focus on inventory reduction. We expect GAAP operating expenses to be approximately $245 million in Q3 and non-GAAP operating expenses to be approximately $180 million. Depreciation is expected to be approximately $45 million in Q3 and $50 million in Q4. This depreciation estimate reflects moving the Electronic Chemicals business to held-for-sale status starting in the second quarter and timing of our capital expenditures. We expect interest expense to be approximately $80 million per quarter going forward until we collect the proceeds from the pending divestiture of EC. We expect the non-GAAP tax rate for the second half of the year to be approximately 15%. The lower expected tax rate in both the second half of this year and going forward is due to the integration of CMC into the Entegris business model. Just to be clear, all the guidance we have provided today, both for Q3 and the full year, includes both the Electronic Chemicals business until it closes and the distribution agreement we have with Element until that fully transitions. I'll now hand it back to Bertrand for some closing remarks. Thank you, Linda. In this uncertain environment, we are showcasing the resilience of our unit-driven business and strong market position. I am also very pleased with the team's execution. We're making great progress on the divestiture of non-core assets. All critical CMC integration milestones are being met, and we will realize the full cost synergies by year-end as planned. We are effectively balancing short-term cost management while making the right investments for the future. We're making those investments because we have conviction in the long-term secular growth of the semiconductor industry and because of our strong conviction in the growing importance of our value proposition, which will translate into an increase in the Entegris content per wafer and Entegris outperformance. With that, operator, let's open the line for questions. The floor is now open for questions. At this time, if you have a question or comment, please press star one on your telephone keypad. If at any point your question is answered, you may remove yourself from the queue by pressing star two. Again, we ask that you pick up your handset when posing your questions to provide optimal sound quality. Our first question is coming from Toshiya Hari with Goldman Sachs. So much for taking the question. I do apologize for, for the background noise. Bertrand, my first question is, is on the market environment. You mentioned, you know, for the full year, you're still expecting, you know, your, your TAM or your SAM to be down in the mid-teens, so, so consistent with what you had said three months ago. I'm guessing you've experienced quite a few puts and takes over the past three months, you know, just based on, you know, what your peers have said on trailing edge being stronger and perhaps advanced logic foundry memory being weaker. Curious, if you can kind of walk through some of the pluses and minuses that you've experienced over the past three months, and if you can point to what your expectations are for both CapEx and MSI for the full year, that would be great. Yes. Good morning, Toshiya. As I said, I mean, the industry remains very dynamic, and it, it is still challenging to really forecast with a great degree of accuracy, and we've seen a lot of puts and take in the market. Our views on, on balance have not really changed all that much since last quarter. When it comes to MSI, we do not really expect any meaningful recovery in, in the back half of the year. We expect a little bit of an uptick in advanced logic and, and likely as well in DRAM. This, this will be offset by some downdraft pressure coming from 3D NAND wafer starts and mainstream wafer starts. Again, a lot of puts and takes here, and not a lot of real recovery in the back half of the year. On the CapEx front, we believe that we have reached bottom in Q2, but we do not really expect any recovery in sight. That's for the industry backdrop, and that's really what leads us to that view that the industry will be down in the mid-teens for us. As you said, in that context, we are pleased with our performance. I mean, our, you know, our Entegris content per wafer continues to grow. We are seeing actually more wafer productions migrating to the leading edge, especially in memory. A lot of the cuts in wafer starts in memory are taking place in older generations of memory. We are seeing more production transferring to the leading edge, where we have higher wafer start, higher content per wafer. That's positive. We are continuing to gain share, we are also, you know, resolving some supply chain constraints that were headwinds in 2022. So that's the basis for the level of outperformance that we expect to deliver in 2023. That's, super helpful, Bertrand. Thank you. Then as my follow-up, I guess on your last point regarding your rate of outperformance, I think for this year, you noted, 6% or higher, which, which again, is consistent with, what you had said three months ago. I know 2024 is, is distant, but, as you think about, you know, your customer technology roadmaps and, and your, your presence across the important inflections in memory and, and advanced logic and foundry, do you think repeating, you know, 6% ± outperformance in 2024 is a high bar? I know in your long-term model, the midpoint, is lower than 6%. Given, you know, gate-all-around, you know, your content growth there, would it be a little, little too much to expect, another year of 6% outperformance in, in 2024? Thank you. Well, Toshiya, I would say two things. I would probably start by saying that it, it's too early for us to talk about 2024, and I probably will end with that same statement. In between those two, you know, beginning points and ending points, I would say that, number one, there are reasons to believe that wafer starts will be a little bit more positive next year. We are keeping an eye on the node transitions that our customers have been talking about, and we expect to see a, a fair amount of activity in terms of node transitions. Again, we know that things change, and that's why I would say that, you know, it's too early for us to go into too many specifics. Got it. Thank you. Our next question comes from John Roberts with Credit Suisse. In FOUPs, just the normal lumpiness of the new fab construction timing, or is it more delays in new fab construction? I don't know if you can untangle those effects. Why wasn't fluid handling affected similarly? It's a great question. It really has to do with the timing of the demand for those products and solutions when new fabs are being built. Typically, fluid handling products are being ordered and used really early on when the buildings are built, when the sub-fab chemical loops are being, you know, installed. That actually happens relatively early in the construction projects. If you look around, there's been a fair amount of activity in terms of new fab constructions this year. Fluid handling products have been benefiting from that. When it comes to FOUPs, the timing of the shipments of those products usually coincide more with the tool deliveries. As we know, the tool intakes have been slowing down, right? That's what has created some, some lumpiness in our FOUP business. That's a business that was actually fairly stable in Q1, but we saw actually a, a, a very significant decline sequentially in Q2. If you go back in time, you will see that that lumpiness is something that we cite very often in a downturn. Those shipments, especially to the large semiconductor manufacturers, can be several millions of dollars, and they can have a big impact quarter to quarter. Having said that, our competitive position remains extremely strong, especially in the leading-edge fabs. It's really a question of timing of shipments as opposed to any concerns you may have in our competitive standing. Great. Thank you very much. Our next question comes from Sidney Ho with Deutsche Bank. Great. Thank you. It's good to hear that you are reiterating your expectation for industry MSI and your own revenue growth this year. My first question is, I have to ask something about AI. At least in the near term, it looks like the demand for GPU is crowding out server demand. How does that impact Entegris? Any way you can help us conceptualize the shift of IT budget from CPU to GPU, how that impacts your business? I don't even know if it's one of, one for one trade-off, but is Entegris content higher for GPU or CPU? If you could include both products from SCEM and MC, that would be great. Yes, i t's a great question. I would just say that, you know, remember that AI, it's exciting. I think it's gonna be a big catalyst for semiconductor demand in the years to come, but today it remains relatively small. It's been growing very rapidly, but it's small. When it comes to the difference in Entegris content between CPUs and GPUs, I would say that we are very well positioned on, on, on those two types of architectures. The one difference, which is positive, is that GPUs typically are larger size dies. And, as we had, I believe, mentioned during a recent Analyst Day, those larger size dies create actually some complexity in terms of defect management. And that actually requires much more focus in terms of the purity of the chemistries that are used. That obviously creates a very significant opportunity for our microcontamination filtration solutions. Okay, that's helpful. My follow-up question is, looking at this, geopolitical tension seems to have stepped up a little bit in the last few months. Clearly, China is trying to build a self-sufficient ecosystem here. Can you talk about the competition in domestic chemicals and material supplies, especially for lagging edge products, which is what all these new fabs seems to be focusing on? Thanks. Sidney, I, I think we've seen the emergence of domestic competitors in China. This is not new. Many of those companies were created 10, 15 years ago, or, or even longer. There's been a big push by our domestic Chinese customers to qualify those domestic alternatives. So far, in many cases, we've been able to demonstrate the superior value proposition of Entegris. I would say that we've been able to hold our share pretty effectively. I think that will likely continue to be the case in the short to mid-term. Having said that, I fully expect to see the emergence of very capable Chinese competitors longer term. That's something that we're gonna continue to watch. The punchline is that today, we continue to compete very effectively in China. You can probably see that in our results in China, which, I mean, we saw a big step down, obviously, following the new export control restrictions between you know, Q3 and Q4 and Q1. Then I think things have stabilized, and we are seeing growth as, you know, the mainstream fabs in China are starting to, you know, to ramp up production. Thank you very much. Our next question comes from Bhavesh Lodaya, with BMO Capital Markets. Hi, good morning, Bertrand and Linda. On your Taiwan facility, can you quantify how much was the startup cost impact for the second, and maybe the third quarter? We have heard around some new announcements for fabs in the region, focused more on AI, perhaps more on the advanced packaging side of things. Any color there around your opportunity set and how it relates to the ramp-up of utilization that you expect for your new facility? Yeah. I mean, the reason we invested in Taiwan is that we actually continue to believe in the importance of the Taiwanese ecosystem. We expect to see significant investments in the years to come, and we wanted to be in a position to appropriately support the growth of our customers and their extended ecosystem. That's why we're investing. And as we said, we, you know, we had a great opening a few months back. Our, our customers are, you know, giving us all of the conviction we need to really accelerate the qualification of those new manufacturing lines. That's, that's our focus. We're not gonna give you a very precise number in terms of the cost headwind. What I can share with you, just as an anecdote, is that, you know, to put some context, is we had about 100 employees at KSP, which is sort of the Kaohsiung site. That's our- the name of our site. At the end of 2022, we expect that number to be about 250 by the end of this year. Remember that we do not expect any meaningful levels of production by the end of this year. It's gonna be a drag. We've talked about it very openly now for several quarters. That's what you're seeing to a great extent in, in the margin guidance that Linda was providing. Got it. Then around the CMC integration, you have spoken about revenue synergies in the past, basically around co-developing your deposition materials, slurries, filter pads. I guess combining the two segments is part of that journey, but any color on how that is progressing? Are you already talking to customers around this? Any color on that? Yes, good question. As we said, there will be a number of different phases for us to unlock the revenue synergies. The first phase is really around cross-selling, and we are really focused for that first phase on mainstream fabs and, in particular, power electronics. We are actually made some really great inroads in combining our SiC slurries with our SiC pads, and and really connecting those solutions to, you know, the best-known methods of filtration. We are actually using the, you know, the sharp increase in volume productions in SiC as a great catalyst to validate this value proposition. That's happening. That's happening now with success. Then the next phase will be about product co-optimization, and we will be doing that in the context of the new nodes. The engagement, the customer engagements are very active, very promising. We've had a lot of those meetings around the world in the recent months. Again, none of that will really be visible on the top line for probably another year or two. Thank you. Our next question comes from Charles Shi with Needham. Hi, thank you for letting me ask the two question- maybe two questions here. First one, Bertrand, you provided Toshiya some good color in terms of end market demand. I want to ask about a different angle. Specifically, on the MSI side, relative to your expectation, let's say, one quarter ago, or advanced foundry logic, mature, and DRAM NAND, relative to your expectation one quarter ago, how does each of the end market are trending up versus down? Specifically, I want, I want to understand, because your full year guidance seems to imply maybe the revenue is gonna bottom either in Q3 or Q4, but one quarter ago, you did expect maybe Q2 was the bottom. Really just want to tie these two things to-together and help us understand what's changed from a quarter ago. Thank you. Yeah, as I said, I mean, there, there are a lot of... it's very choppy in, in the industry right now, and our views have, have, have evolved for sure. You know, we are today probably a little bit more bullish about DRAM than we were a few months ago, recognizing that we have less exposure to DRAM than we do to 3D NAND, right? I think we are probably a little bit more pessimistic about 3D NAND today than we were, you know, a couple of quarters ago. Which translates into, you know, probably more modest views in terms of wafer starts for 3D NAND in, in the back half of the year. We're also seeing some pushouts in node transitions in, in 3D NAND, both of which have, have some impact on, on our business. Advanced logic is expected to recover, in, you know, in a modest way in the back half of the year, and that's good news for us. We're also seeing, you know, some interesting node transitions in the back half of the year, and that's good news for us as well. Then for mainstream, I think we always expressed some concern that there could be some softening in the back half of the year. That's something we always kind of anticipated, and we are seeing certainly the materialization of, of this, and then we're taking that into account in our forecast for the full year. Thank you, Bertrand. I really wanna ask a more long-term question, combining SCEM and APS. We did hear from one of your team members, very recently in an investor event earlier, actually in July, that some of the future opportunities would include advanced packaging. I thought advanced packaging wasn't really a major focus for Entegris in the past, but, it's interesting to see advanced packaging being one of the growth opportunities, that, your team is seeing over a longer period of time. Can you, help us understand why the change? Especially in advanced packaging, a lot of the complexity may not be as, it may not be as complex as in the wafer fab space. Why do you see a major opportunity there? Well, just help us understand, what, what your teams are seeing today. Thank you. Yeah. You're right, that there are a number of roadmaps in the industry that, in the past, traditionally did not require the advanced solutions that we are developing. It's true for advanced packaging. It was true also for DRAM. The good news is that all of those roadmaps are becoming much more demanding. You know, in advanced packaging, I think, we expect a much greater degree of, you know, precision, of automation, a degree of, you know, cleanliness required in their processes. We also believe there will be more polishing step required, with, you know, the bonding of the wafers. All of that will open up opportunities for our AMH products in terms of, you know, wafer carriers, slurries and pads for the polishing applications, and very likely also, you know, opportunities for our filtration and cleaning product line. That's something that we are very focused on today. Again, to expand that, I would say that the similar, the similar view in terms of the DRAM roadmap, again, typically, the Entegris content per wafer on a DRAM chip is way less than 3D NAND or logic, but this is changing. You know, in the case of DRAM, we're seeing a push for more miniaturization. We're seeing a push for, you know, 3D architectures on the backside of, of the chip, all of which will create opportunities for our microcontamination solution set. You know, will require new precursor for the new films and, and, you know, highly selective etching chemistries will also be required for the upcoming DRAM architecture. If you look across the board in, in the semiconductor industry, we are increasingly excited about the various roadmaps, and we believe there will be many opportunities for us to continue to increase the Entegris content per wafer. Thank you, Bertrand. Our next question comes from Kieran de Brun with Mizuho. Hi, good morning. Thanks for taking my question. Good morning. I wonder just to, just to start off, maybe on SCEM, can we talk about the mix that you've been seeing, like how we should be thinking about margins going forward? If there's any color on how you think about exiting the year, as some of these kind of mixed headwinds seem to lap or abate as we get into the end of the year, that would be helpful. Thank you. Yeah, when it comes to SCM, remember that, you know, we've been very clear now for several years that this is an area where we see a lot of opportunities. I mean, back to the comment I was making in the context of DRAM, 3D NAND, or even just advanced packaging, I think that now is the time to really enable the new materials and chemistries that will support the ambitious roadmaps of our customers. We want to be investing, and that's why the, the bottom line performance of SCM is very, you know, modest this year, around 10%. We expect some very modest recovery in the back half of the year, but really, the recovery will come with the adoption of the new materials that we're developing. We need those materials to reach high volume. If you go back to the Analyst Day last year, you will notice that SCEM was expected to be the lower, I mean, the, the, you know, the, the lower margin business of the, of the four divisions. That is a function of the level of investment we intend to make there. Remember, in terms of the external reporting, with the combination of APS and SCEM, you know, we intend to have a three-segment reporting starting Q3. Okay, that's, that's very helpful. Then maybe just on the combination of SCEM and APS. I think back in the Analyst Day, APS was growing at, like, a 200-400 basis point above market, whereas SCEM is in kind of the broader range of, like, the 300-600 basis points. You know, when we factor in revenue synergies and the integration of CCMP, how do you think about that combined segment? Should we be thinking about it in that kind of 300-600 basis point range going forward, or is there probably gonna be a little bit of a, a lower growth rate versus the broader market when we think about the combination of both businesses? If so, is the ambition to get it back up to kind of that 300-600 basis points? Thank you. Yeah, we, we have a high degree of conviction in, in the, the power of this combination and the ability to really develop very unique end-to-end solutions for, for our customers. And that's gonna translate into superior growth longer term, right? We will, we will reset those expectations. We're thinking about having potentially an Analyst Day in the first half of next year. That's gonna be an opportunity for us to actually reset some of those expectations in terms of top line growth potential and, and bottom line potential for each of the three divisions. Fantastic. Thank you. Our next question comes from Aleksey Yefremov with KeyBanc Capital Markets. Thanks. Good morning, everyone. This is Ryan on for Aleksey. I guess the first question I would have, just starting in MC, you guys flagged, you know, headwinds from lower production in 2Q. First off, wondering if you guys might be able to quantify that for us. Then secondly, just, you know, what are your expectations on, you know, potential headwinds from, from the same thing in the back half? Thanks. Yeah, I mean, I think those supply chain constraints have been easing, that's the point I was trying to make. There are some modest lingering supply chain constraints, but it's really not very material. We expect, I mean, of course, year to date, microcontamination has been the, you know, the shining star of our portfolio. You know, it's, it's up 2% year to date. In particular, our liquid filtration platform has been growing very nicely. We delivered a record quarter, actually, in Q2 this year, in spite of the industry conditions that you are well aware of. Again, it's just a validation of the growing importance of those filters when it comes to yield optimization, when it comes to, you know, chip long-term reliability. We expect, again, this, this business to continue to do very well in the back half of the year. Great, very helpful. Then just secondly, you know, just looking at kind of like what the implied EBITDA is for 4 Q, it looks like there's a, you know, a fairly strong, you know, step up 3 Q to 4 Q. Just wondering if you could talk about some of the drivers there. Thanks. Yeah. As we think about, you know, moving into Q4, I mean, a lot of it is gonna be mix. As we've seen so far, we have seen some strength in our unit-driven businesses like MC, which does have a good mix impact with that business. Then, you know, we do have the, the on the CapEx side, the businesses tied more to the fab construction. That will be a big piece of it. Secondly, we are gonna continue to focus on cost controls. It's, it's really critical as we balance throughout the year, to balance cost controls against investment. As we think about that balancing, that is what we're focused on. We did hold our guidance for the full year and hold our guidance on the EBITDA margin, that is another piece of the puzzle that we're balancing. Our next question comes from Timothy Arcuri with UBS. Thanks a lot. Can you talk about the puts and the takes on the model with these different moving parts? I mean, obviously, we're gonna lose EC. You lose some revenue, but it obviously helps margins. You have the termination of the Element Solutions deal. You get some cash, but you have to kind of, you know, rebuild that channel for these plating chemistries. You know, that might not be a factor because you just use your existing channel. I'm, I'm just kind of wondering if, like, maybe you could take December, and you could sort of rightsize the base for us. You know, what it looks like, sort of on a pro forma basis, as you enter 2024. Thanks. Yeah. So, Tim, I probably can take the lead here. Just to probably say that, yeah, it's there are a lot of moving pieces to your point, and it would be probably more confusing than helpful to really try to unpack everything. I will only cite a couple of factors, though. One is the termination of the distribution agreement with Enthone, for instance, will have actually a pretty significant detrimental impact on gross margin in Q3 and potentially Q4. The reason being that, while we collected the proceeds, we still need to serve existing customers, but we'll do that at, at zero margin, until all of the customer transitions are completed. That's gonna have an impact of about, you know, 0.5 points of gross margin, roughly. Again, I think there are a lot of puts and takes. The takeaway for you is really that indeed, once all of those divestitures are completed, the financial profile of the company will be different and will be more attractive. That's one of the reasons why we think that we have to do an Analyst Day sometime in the first half of next year to actually, you know, show you what Entegris looks like once all of those divestitures are completed, and talk about the long-term potential of the platform. That's not something we're gonna be doing on the call today. Thanks a lot, Bertrand. Okay. Yeah, I, I get that there's a lot of moving parts. There was a question before on China. I guess my, my question. I mean, certainly they are making huge investments. They're making big investments in chemistries and things that they ultimately hope will displace, you know, companies like you. Sort of how do you handicap? There was a question sort of, you know, generally about the risk, but how do you isolate what your portion of, you know, revenue is going into the domestic China chipmaker? I know that as you reported, it's roughly 15% of revenue, but that's not just domestic China chip makers. How do you sort of, you know, handicap and ring-fence what is going into the domestic China guys? Yeah. What we've said, it's about, you know, it's about two third would be domestic, I mean, a high level. And that's, you know, that's something that obviously, given the current, you know, regulations, we are paying very, very close attention to, and we are engaging with individual customers, asking them to represent to us that they are operating their fabs within the permissible, you know, technology nodes. And that's something that, you know, we're gonna continue to operate very, very precisely. I'm not sure exactly what, what is behind your question, Tim. Maybe you can help me, but... Yeah, I guess, Bertrand, I ask because it, it does appear likely that there's gonna be some push to restrict, even, you know, lagging edge nodes. I, you know, I don't know what they're gonna do, but certainly there's, you know, where there's, where there's, you know, smoke, there's, you know, typically fire. I'm just wondering how you could get nicked in that. I'm just kind of trying to ring-fence what's going to the domestic China companies, which, you know, most of which would be lagging edge because of the current restrictions. Yeah, I mean, I can only talk to you about the existing restrictions. I will not speculate on, you know, a new wave of, of, export controls or any other measure. I mean, that's. I don't have any unique knowledge, and I won't speculate on that. We'll talk about it if, if there's anything specific that, that is enacted. Perfect, Bertrand. Thank you. Our next question comes from Mike Harrison with Seaport Research Partners. Hi, good morning. Can you hear me okay? Yes, good morning. Yes. Thanks. Was hoping that maybe you could talk a little bit about the mix that you're seeing within the planarization business. You said that volumes sequentially were lower across most product lines, but I know you called out that SiC opportunity, which I believe is, is small today, but growing nicely. Just curious, are you expecting to see a faster recovery within some of the more advanced slurries as you look at the second half and into 2024? I would say that when I look at the APS results, they are mostly in line with our expectations, especially given the very depressed environment that we've experienced in memory. The bright spot has been, and we expect it to continue to be, the SiC application, both for slurries and pads. That part of the business has been growing year-on-year, growing sequentially, and we expect that to continue to be the case in the back half of the year. We also expect to turn a corner in silicon applications. I would expect overall APS to have a better second half than the performance we saw in the first half. All right, thank you. Then, just in terms of the CapEx reduction, in your outlook for this year, can you give us any sense of what's being delayed? I assume that's not any delay in the ramp-up of Taiwan, but is any of that related to the work that you're doing in Colorado Springs? Yeah. We remain very focused on the growth in Taiwan and Colorado Springs, so it's, it's nothing specific to that timing. You know, it was a general delay. Also, as we said, you know, we're looking at the market environment. Having less CapEx is gonna benefit us from a cash standpoint and ties very well to the market environment, as well as our goals to continue to pay down debt. Perfect. Thank you very much. Our next question comes from Chris Kapsch with Loop Capital Markets. Hi, good morning. Thanks for squeezing me in. So my questions were focused on the APS or the slurry business. You just provided some color there, but I'm curious if you could just characterize if there's been any change in the competitive landscape for slurries generally, given the memory and market weakness? Then more specifically, just curious how the tungsten slurry business is doing, maybe as gauged by content per wafer when looking at those advanced, more complex 3D NAND architectures. Also, how is the advanced oxide slurry business doing, given what I believe is a, you know, an advantage proprietary position there? Yeah. Look, I mean, I would say that right now the competitive position has, has not changed all that much, right? Then we are not losing any share, we're not gaining any share that would impact the short-term results. I would tell you that there are a number of new design wins that we've been able to, to get awarded, that are very interesting and very exciting, especially around advanced dielectrics, and that actually is both in, in, in, in logic and memory. That's one of the reasons I answered the question the way I did to a previous question about, can we legitimately expect APS to grow at a, at a growth rate similar to SCEM in the years to come? I would say it's a fair expectation, and that goes back to the commitment we made to unlock positive revenue synergies as we learn to better optimize and co-optimize our solutions across the platform. As I said, customers are very receptive to this, you know, possibility and hypothesis, and we're working very, very hard to, you know, to actually unlock the full potential of the platform, and that's gonna translate into growth, both in slurries and a number of ancillary products. Got it. That's helpful. Just as one follow-up, and I'm just inferring from your answer there, that, you know, the, the content per wafer, per, per, per die, if you will, and advanced memory is increasing, but it sounds like it's maybe more driven by oxide polishing versus tungsten. Any comment there, or maybe maybe it's both in terms of visibility around process of record? Yeah. I'm, I'm not sure I want to go... I, I'm not sure I'm gonna go into that level of specificity, in, in, in this calls, but I think, you know, across the board, we're making some, some good progress. Thank you. We have reached our allotted time for our question-and-answer session. I will now turn the floor back over to Bill Seymour for some closing remarks. Thank you everyone for joining today. Please follow up with me if you have any questions. Have a great day, and you can now disconnect. Thank you. This concludes today's Entegris second quarter 2023 earnings conference call. Please disconnect your line at this time and have a wonderful day.